top of page

Revolutionizing the treatment of COPD

Playing Guitar

OUR STORY

Chronic Obstructive Pulmonary Disease (COPD) is a debilitating condition in which chronic inflammation of the lung airways leads to difficulty breathing.  Despite continued advancement in therapies, many patients cannot be adequately managed via currently available medications and pulmonary rehabilitation.  To address this unmet clinical need, Ryme Medical is developing a catheter-based therapy that seeks to reduce symptoms and improve long-term outcomes in patients with COPD.

TEAM

SMALL TEAM. BIG VISION.

Our vision is clear – to reduce the suffering of patients with COPD.  Our desire to improve the lives of patients struggling with this debilitating disease drives all our thoughts and actions.  We couple this mindset with our commitment to integrity, quality, rapid device iteration and evidenced based medicine in hopes that our novel therapy will one day improve the lives of millions of people.  To achieve this ambitious goal, we have assembled a seasoned team with years of experience and a history of success developing new therapeutic products. 

_edited_edited.png

DID YOU KNOW? 

  • COPD affects over 320 million people worldwide

  • The U.S. spends over $50 billion annually treating COPD​

   1

  2

PARTNERS

To be successful, companies need more than just a great idea and a great team, they need the support of investors and advisors. Ryme Medical is fortunate to be supported by four of the most seasoned and successful groups in the MedTech industry.

SanteLogo_edited.jpg

Founded in 2006, Santé Ventures is a specialized healthcare and life sciences investment firm with nearly $800M in capital under management. The firm invests in early-stage companies developing innovative new medical technologies, biotechnologies, and digitally enabled healthcare services. Santé invests nationally and has offices in Austin, TX, and Boston, MA. For more information, please visit www.sante.com.

Epidarex Capital Logo (002).jpg
Seroba-Plain-Logo-Medium-Digital-use (00

Seroba is a European life sciences venture capital firm based in Dublin, Paris and Milan, investing from its fourth Fund. Seroba focuses on value creation through backing cutting-edge biotech and medtech innovation that will transform the treatment of patients, addressing unmet medical needs. The Seroba team has deep industry, operational and investing experience and an extensive global network. 

For more information, please visit  www.serobavc.com

fogartylogo.png

Epidarex is a transatlantic venture capital firm with a diverse team of early-stage investors known for our track record of building breakthrough life sciences companies in emerging hubs. We are trusted partners with our founders and co-investors and use our deep scientific and industry network to create exceptional value and shared success. For more information, please visit  www.epidarex.com

Fogarty Innovation is the leading MedTech educational incubator located in Silicon Valley. The organization is led by a team of experienced entrepreneurs and executives, most of whom have over 20 years of experience bringing new technologies to market. Our partnership allows us to tap into this knowledge, creating a network of trusted advisors for our company. For more information, visit www.fogartyinnovation.org

CAREERS



The success of any company depends on the quality and commitment of their employees. To this end, we aim to attract the best and brightest and seek to provide them with opportunities for personal and professional development as our company grows. As new positions become available, we will post job descriptions here.  

NOT JUST A PLACE TO WORK, BUT A PLACE TO GROW

CONTACT

Office

2495 Hospital Drive, Suite 300
Mountain View, CA 94040

info@rymemedical.com

bottom of page